Sascha Mielcarek

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), has initiated a policy roundtable with German regulators on adult-use cannabis legalization in Germany. In this meeting, the German Drug Commissioner, Burkhard Blienert, presented the plan for adult-use cannabis legalization and repeated the German...

Tilray Brands, Inc. (NASDAQ: TLRY), a Canada-based cannabis company, announced on Tuesday that subsidiary Tilray Medical has launched a new educational platform called WeCare-MedicalCannabis to provide education about the benefits of medical cannabis to consumers and medical practitioners,...

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, launched a new cannabis education platform, WeCare-MedicalCannabis, dedicated to providing resources and educating healthcare practitioners and patients about medical cannabis. WeCare-MedicalCannabis...

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) welcomed the Luxembourg Ministry of Health delegation to the company’s European campus and facility located in Cantanhede, Portugal. Tilray’s EU-GMP-certified medical cannabis cultivation and manufacturing facility in Portugal provides...

Tilray Inc (NASDAQ: TLRY) has expanded its outdoor medical cannabis growing capacity by adding 20 additional hectares to its Alentejo, Portugal campus. The additional land aims to expand the cultivation site, which already has 6,500 square meters of outdoor growing space, in addition to five...